InvestigatorCIMIT FriendIndustryPatient
search
How Engineering Is Enhancing Cardiovascular Diagnosis and Therapy

3.17.2009

Multi-Parameter Assay for Personalized Targeting and Monitoring of Anti-Thrombotic Therapy

SPEAKER:
Kumaran Kolandaivelu, MD, PhD: BWH

MODERATOR:
Elazer R. Edelman, MD, PhD, FACC:
MIT, HMS, BWH

 

 

   
SHARE THIS PAGE: Bookmark and Share - Email to a friend or add this page to a website.

EMBED THIS VIDEO:


Forum Abstract

Multi-Parameter Assay for Personalized Targeting and Monitoring of Anti-Thrombotic Therapy

Thrombosis forms the pathophysiological basis for a number of common cardiovascular diseases, yet tools to effectively predict an individual’s thrombotic risk are lacking. We are creating a point-of-care diagnostic tool that will better monitor and individualize anti-thrombotic use in complex clinical settings such as following myocardial infarction. Our approach implements the concepts first described by Virchow years ago to provide a high resolution, virtually instantaneous, personalized assay of thrombotic state, which we call the “thrombotic fingerprint”. The simultaneous consideration of multiple parameters is a novel approach that allows for a refined assessment of individual thrombotic risk. The assay provides a powerful means by which to titrate drugs with narrow therapeutic indices to suite an individual’s need and to monitor the effectiveness of complex, ever-evolving, combination-drug therapies.

Post a Comment



Get Involved Support CIMIT's Mission Join Industry Liaison Program Apply for Grant Contact Us

CIMIT does not rate, endorse, recommend or prescribe any products, procedures or services. Subscribe to CIMIT News in RSS

Contact the Webmaster Site Acknowledgements Copyright © 2010 CIMIT. All rights reserved. site map linking policy privacy